Clinical trial
A Randomized, Open-label, Two-way Crossover Trial to Determine the…
NCT00139893 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00139893 |
|---|---|
| Title | A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis |
| Official title | A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetic Gastroparesis |
| Intervention type | Drug |
| Interventions | Reglan ODT |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2005 |
| First posted | Aug 31, 2005 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: